<p><b>A</b>) Mice were injected with 1×10<sup>6</sup> live MCA-205, MCA-205-OVA, MCA-205-E1A-Δp300-OVA, or MCA-205-E1A-OVA tumor cells in the flank s.c. and an <i>in vivo</i> CTL assay against OVA pulsed splenocytes was performed seven days later. Data shown is the mean ± SEM from three experiments, with six mice per group. Data were analyzed by ANOVA followed by Tukey's HSD post hoc analyses. **, p<.01; ***, p<.001.</p
<div><p>CTLs from OVA-vaccinated and mock-vaccinated mice were analyzed in parallel using an MHC arr...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p><b>A</b>) Cell lysates were immunoprecipitated for OVA followed by Western blotting for OVA. West...
<p>Mice were injected with 1×10<sup>5</sup> live MCA-205, MCA-205-OVA, MCA-205-E1A-Δp300-OVA, or MCA...
<p>(A) 1×10<sup>5</sup> CD90-selected splenic T cells of mice challenged with 291OVA cells were rest...
<p>(<b>A</b>) B6 or SM-Ova mice were immunized with rAAV-Ova, replicative VSV-Ova or live Lm-Ova. Se...
<p>C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-OVA, BV-...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>C57BL/6 mice were immunized with PBS, iDC, DCs-OVA (DCs pulsed with OVA<sub>257–264</sub>), Rv065...
<p>(A, B) C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-O...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p><b>A</b>) Representative gating strategy to determine immune infiltrate of MCA-205-OVA tumors. B6...
<p>(A) FACS analysis of brain infiltrating lymphocytes (BIL) from mice infected with TMEV-L/OVA for ...
Control and mLN resected mice (n = 3–4) were orally challenged with OVA-CT. 25 days after the challe...
<p>RAGE sufficient or deficient OT-II TCR-Tg mice were immunized with intranasal OVA as described in...
<div><p>CTLs from OVA-vaccinated and mock-vaccinated mice were analyzed in parallel using an MHC arr...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p><b>A</b>) Cell lysates were immunoprecipitated for OVA followed by Western blotting for OVA. West...
<p>Mice were injected with 1×10<sup>5</sup> live MCA-205, MCA-205-OVA, MCA-205-E1A-Δp300-OVA, or MCA...
<p>(A) 1×10<sup>5</sup> CD90-selected splenic T cells of mice challenged with 291OVA cells were rest...
<p>(<b>A</b>) B6 or SM-Ova mice were immunized with rAAV-Ova, replicative VSV-Ova or live Lm-Ova. Se...
<p>C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-OVA, BV-...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>C57BL/6 mice were immunized with PBS, iDC, DCs-OVA (DCs pulsed with OVA<sub>257–264</sub>), Rv065...
<p>(A, B) C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-O...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p><b>A</b>) Representative gating strategy to determine immune infiltrate of MCA-205-OVA tumors. B6...
<p>(A) FACS analysis of brain infiltrating lymphocytes (BIL) from mice infected with TMEV-L/OVA for ...
Control and mLN resected mice (n = 3–4) were orally challenged with OVA-CT. 25 days after the challe...
<p>RAGE sufficient or deficient OT-II TCR-Tg mice were immunized with intranasal OVA as described in...
<div><p>CTLs from OVA-vaccinated and mock-vaccinated mice were analyzed in parallel using an MHC arr...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p><b>A</b>) Cell lysates were immunoprecipitated for OVA followed by Western blotting for OVA. West...